87 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
![]() |
Translating clinical trials from human to veterinary oncology and back. |
Fürdös I, Fazekas J, Singer J, Jensen-Jarolim E |
Journal of translational medicine. 2015 Aug 15. doi: 10.1186/s12967-015-0631-9. pii: 10.1186/s12967-015-0631-9. pmc: PMC4536666 |
PMID: 26275615 |
Crosstalk of carcinoembryonic antigen and transforming growth factor-β via their receptors: comparing human and canine cancer. |
Jensen-Jarolim E, Fazekas J, Singer J, Hofstetter G, Oida K, Matsuda H, Tanaka A |
Cancer immunology, immunotherapy : CII. 2015 Apr 2. doi: 10.1007/s00262-015-1684-6. pmc: PMC4412651. mid: EMS63119 |
PMID: 25832000 |
Immune suppressive effect of cinnamaldehyde due to inhibition of proliferation and induction of apoptosis in immune cells: implications in cancer. |
Roth-Walter F, Moskovskich A, Gomez-Casado C, Diaz-Perales A, Oida K, Singer J, Kinaciyan T, Fuchs HC, Jensen-Jarolim E |
PloS one. 2014 Oct 1. doi: 10.1371/journal.pone.0108402. pii: PONE-D-14-12496. pmc: PMC4182734 |
PMID: 25271635 |
IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach. |
Singer J, Jensen-Jarolim E |
Journal of carcinogenesis & mutagenesis. 2014 Sep 29. doi: 10.4172/2157-2518.1000176. pmc: PMC4174352. mid: EMS60228 |
PMID: 25264496 |
B cells and ectopic follicular structures: novel players in anti-tumor programming with prognostic power for patients with metastatic colorectal cancer. |
Meshcheryakova A, Tamandl D, Bajna E, Stift J, Mittlboeck M, Svoboda M, Heiden D, Stremitzer S, Jensen-Jarolim E, Grünberger T, Bergmann M, Mechtcheriakova D |
PloS one. 2014 Jun 6. doi: 10.1371/journal.pone.0099008. pii: PONE-D-14-04301. pmc: PMC4048213 |
PMID: 24905750 |
Generation of a canine anti-EGFR (ErbB-1) antibody for passive immunotherapy in dog cancer patients. |
Singer J, Fazekas J, Wang W, Weichselbaumer M, Matz M, Mader A, Steinfellner W, Meitz S, Mechtcheriakova D, Sobanov Y, Willmann M, Stockner T, Spillner E, Kunert R, Jensen-Jarolim E |
Molecular cancer therapeutics. 2014 Apr 22. pii: 1535-7163.MCT-13-0288. doi: 10.1158/1535-7163.MCT-13-0288. pmc: PMC4174294. mid: EMS60298 |
PMID: 24755200 |
Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells. |
Oida K, Matsuda A, Jung K, Xia Y, Jang H, Amagai Y, Ahn G, Nishikawa S, Ishizaka S, Jensen-Jarolim E, Matsuda H, Tanaka A |
Scientific reports. 2014 Feb 17. pii: srep04057. doi: 10.1038/srep04057. pmc: PMC3925966 |
PMID: 24531845 |
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R. |
Mirkina I, Hadzijusufovic E, Krepler C, Mikula M, Mechtcheriakova D, Strommer S, Stella A, Jensen-Jarolim E, Höller C, Wacheck V, Pehamberger H, Valent P |
PloS one. 2014 Jan 29. doi: 10.1371/journal.pone.0084417. pii: PONE-D-13-39207. pmc: PMC3906015 |
PMID: 24489649 |
Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2/neu breast cancer patients. |
Petricevic B, Laengle J, Singer J, Sachet M, Fazekas J, Steger G, Bartsch R, Jensen-Jarolim E, Bergmann M |
Journal of translational medicine. 2013 Dec 12. pii: 1479-5876-11-307. doi: 10.1186/1479-5876-11-307. pmc: PMC4029549 |
PMID: 24330813 |
IgE-based immunotherapy of cancer: challenges and chances. |
Singer J, Jensen-Jarolim E |
Allergy. 2013 Oct 14. doi: 10.1111/all.12276. pmc: PMC4022995. mid: EMS58513 |
PMID: 24117861 |
Activation-induced cytidine deaminase (AID) linking immunity, chronic inflammation, and cancer. |
Mechtcheriakova D, Svoboda M, Meshcheryakova A, Jensen-Jarolim E |
Cancer immunology, immunotherapy : CII. 2012 Apr 19. doi: 10.1007/s00262-012-1255-z. pmc: PMC3427704. mid: UKMS48526 |
PMID: 22527246 |
Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting. |
Singer J, Weichselbaumer M, Stockner T, Mechtcheriakova D, Sobanov Y, Bajna E, Wrba F, Horvat R, Thalhammer JG, Willmann M, Jensen-Jarolim E |
Molecular immunology. 2012 Mar 19. pii: S0161-5890(12)00003-X. doi: 10.1016/j.molimm.2012.01.002. pmc: PMC3318186 |
PMID: 22424313 |
Cancer vaccines inducing antibody production: more pros than cons. |
Jensen-Jarolim E, Singer J |
Expert review of vaccines. 2011 Sep 16. doi: 10.1586/erv.11.105 |
PMID: 21919618 |
Phylogenetic discordance of human and canine carcinoembryonic antigen (CEA, CEACAM) families, but striking identity of the CEA receptors will impact comparative oncology studies. |
Weichselbaumer M, Willmann M, Reifinger M, Singer J, Bajna E, Sobanov Y, Mechtcherikova D, Selzer E, Thalhammer JG, Kammerer R, Jensen-Jarolim E |
PLoS currents. 2011 Mar 16. doi: 10.1371/currents.RRN1223. pii: k/-/-/1glqeci8ut3qh/8. pmc: PMC3059814 |
PMID: 21436956 |
Mimotope vaccination--from allergy to cancer. |
Knittelfelder R, Riemer AB, Jensen-Jarolim E |
Expert opinion on biological therapy. 2009 Apr 6. doi: 10.1517/14712590902870386. pmc: PMC3049225. mid: UKMS32992 |
PMID: 19344285 |
AllergoOncology: the role of IgE-mediated allergy in cancer. |
Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodríguez JA, Siccardi AG, Vangelista L, Riemer AB, Gould H |
Allergy. 2008 Jul 26. pii: ALL1768. doi: 10.1111/j.1398-9995.2008.01768.x. pmc: PMC2999743. mid: UKMS32996 |
PMID: 18671772 |
Immunization with mimotopes prevents growth of carcinoembryonic antigen positive tumors in BALB/c mice. |
Brämswig KH, Knittelfelder R, Gruber S, Untersmayr E, Riemer AB, Szalai K, Horvat R, Kammerer R, Zimmermann W, Zielinski CC, Scheiner O, Jensen-Jarolim E |
Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Nov 2. pii: 13/21/6501. doi: 10.1158/1078-0432.CCR-07-0692 |
PMID: 17975163 |
Mimotope vaccines: epitope mimics induce anti-cancer antibodies. |
Riemer AB, Jensen-Jarolim E |
Immunology letters. 2007 Aug 22. pii: S0165-2478(07)00155-1. doi: 10.1016/j.imlet.2007.07.008. pmc: PMC2999752. mid: UKMS33000 |
PMID: 17825923 |
Active induction of tumor-specific IgE antibodies by oral mimotope vaccination. |
Riemer AB, Untersmayr E, Knittelfelder R, Duschl A, Pehamberger H, Zielinski CC, Scheiner O, Jensen-Jarolim E |
Cancer research. 2007 Apr 5. pii: 67/7/3406. doi: 10.1158/0008-5472.CAN-06-3758 |
PMID: 17409451 |
Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes. |
Riemer AB, Förster-Waldl E, Brämswig KH, Pollak A, Zielinski CC, Pehamberger H, Lode HN, Scheiner O, Jensen-Jarolim E |
European journal of immunology. 2006 May 1. doi: 10.1002/eji.200535279 |
PMID: 16568495 |
87 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
![]() |